Average obligated amount per year since period start.
Portion of total contract value already obligated.
Share of total value represented by subawards.
BIOLINK - TO INVESTIGATE AND DETERMINE IF TREATMENT WITH RAMATROBAN, ADMINISTERED FOR 28 DAYS TO HOSPITALIZED, NON-ICU PATIENTS WITH COVID-19 PNEUMONIA, REDUCES THE RISK OF SUBSEQUENT DEVELOPMENT OF PASC OVER THE ENSUING 11 MONTHS. PROVIDED DATA
Task order obligations
Estimated months remaining until end of performance.
Period of performance
100% of period elapsed
Loading contract activity data...
Modification ID | Description | Action Date | Obligated Amount | Action Type |
|---|---|---|---|---|
Subaward # | Subawardee | Description | Amount | Action Date |
|---|---|---|---|---|